Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

GSK forms leading consumer health JV with Novartis; later GSK buys out stake

27 Mar 2018

Executive Summary

Creating what Deutsche Bank analysts say will be the top OTC business in the world, GlaxoSmithKline PLC and Novartis AG formed a consumer health joint venture. Ownership will be split 63.5% GSK/36.5% Novartis, with the JV operating under GSK’s GlaxoSmithKline Consumer Healthcare division.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By